Innov Clin Neurosci. 2015;12(5–6 Suppl B):3–19. CNS Drug Compounds/Therapies/Devices Long-acting injectable antipsychotics (LAIs) in outpatient treatment of DMS-IV-R schizophrenia Presenters: Bellnier T, Patil K, Ortega T, Seeger G Affiliations: SUNY
by Jared W. Young, PhD; William Z. Potter, MD, PhD; Steve Riley, PharmD, PhD; Geert J. Groeneveld, MD, PhD; Bruce J. Kinon, MD; Mike F. Egan, MD; and Douglas E.
by Steven T. Szabo, MD, PhD; Bruce J. Kinon, MD; Stephen K. Brannan, MD; Andrew K. Krystal, MD, MSc; Joop M A van Gerven, MD, PhD; Atul Mahableshwarkar, MD; and
by Harald Murck, MD, PhD; Thomas Laughren, MD; Femke Lamers, PhD; Rosalind Picard, ScD; Sebastian Walther, MD; Donald Goff, MD; and Stephen Sainati, MD, PhD Dr. Murck is with Acorda
by Radhika Bawa, MD, and Jonathan R. Scarff, MD Dr. Bawa is with Lehman College, the City University of New York, Bronx, New York; and Dr. Scarff is with Veterans
by Jae Lee, DO; Puneet Narang, MD; Manasa Enja, MD; and Steven Lippmann, MD Dr. Lee is resident physician at Hennepin-Regions Psychiatry Program, Minneapolis-St. Paul, Minnesota; Dr. Narang is staff
by Richard G. Cockerill; Bridget K. Biggs, PhD; Tyler S. Oesterle, MD; and Paul E. Croarkin, DO Mr. Cockerill is a student at Mayo Medical School, College of Medicine, Mayo
by Michael D. Shuman, PharmD, and Ian R. McGrane, PharmD Dr. Shuman is Assistant Professor, Pharmacy Practice, Rosalind Franklin University of Medicine and Science College of Pharmacy, North Chicago, Illinois,
by Steven D. Targum, MD Dr. Targum is with Clintara, LLC, Boston, Massachusetts. Innov Clin Neurosci. 2014;11(3–4):24–28
by Randy A. Sansone, MD, and Lori A. Sansone, MD R. Sansone is a professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine
by Thomas Shiovitz, MD; William M. Greenberg, MD; Changzheng Chen, PhD; Giovanna Forero, MA; and Carl P. Gommoll, MS Dr. Shiovitz with the California Neuroscience Research Medical Group Inc, Sherman
Dear Editor: Antidepressant-induced excessive sweating (ADIES) is a common antidepressant-related side effect, and its prevalence is estimated to range from 4 to 22 percent.[1] Adverse effects are a common reason
Oleg V. Tcheremissine, MD, and Danielle Englert, MD Dr. Tcheremissine is Research Director, Department of Psychiatry and Behavioral Sciences, Carolinas Healthcare System; Dr. Englert is Director of Deep Brain Stimulation
by Eileen Trigoboff, RN, DNS; Jeffery Grace, MD; Herman Szymanski, MD; Jaspinder Bhullar, MBBS; Claudia Lee, MD; and Thomas Watson, RN, MSN Drs. Trigoboff, Grace, and Lee are from the
by Farid Ramzi Talih, MD Dr. Talih is Assistant Professor of Psychiatry at the Department of Psychiatry of the American University of Beirut Medical Center, Beirut, Lebanon. Innov Clin Neurosci.
Vikas Mangewala, MD; Sajjad Sarwar, MD; Ryan Rosenberger; Theodor Rais, MD; and Michele Knox, PhD Drs. Mangewala and Sarwar are Fellows, Child and Adolescent Psychiatry; Mr. Rosenberger is a medical
Randy A. Sansone, MD, and Robert J. Sawyer, MD Dr. Sansone is a Professor in the Departments of Psychiatry and Internal Medicine at Wright State University School of Medicine in
by Alicia Hanes, Tammie Lee Demler, Claudia Lee, and Alexander Campos Drs. Hanes and Compos are from University at Buffalo, School of Pharmacy and Pharmaceutical Sciences, Buffalo, New York; Drs.
by Akihide Wakamatsu, Kazuo Aoki, Yojiro Sakiyama, Takashi Ohnishi, and Makoto Sugita All from the CNS Department, Scientific Affairs Division, Janssen Pharmaceutical K.K., Tokyo Japan Innov Clin Neurosci. 2013;10(3):23–30
by Anna I. Guerdjikova, PhD, and Susan L. McElroy, MD Dr. Guerdjikova is from the Lindner Center of HOPE in Mason, Ohio, and Dr. McElroy is from the Department of
